The Joint ECOG-ACRIN Program supports cancer researchers expanding innovative phase II trials into community care settings, with the goal of reducing cancer’s burden and improving adults’ quality of life and survival.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
ACG Established Investigator Bridge Funding Award supports established clinical scientists’ digestive and liver disease research during federal funding gaps to sustain independent research programs.
Institutional Research Grants support early-career cancer investigators with seed funding for pilot projects that generate preliminary results and help them compete for larger national research awards.
Cancer Center Community-Academic Collaborative Program Award supports community-academic partners implementing and evaluating evidence-based cancer programs to address Indiana’s cancer burden.